Bkaily G, Caillé J P, Payet M D, Peyrow M, Sauvé R, Renaud J F, Sperelakis N
Department of Physiology and Biophysics, Faculty of Medicine, Université de Sherbrooke, Qué., Canada.
Can J Physiol Pharmacol. 1988 Jun;66(6):731-6. doi: 10.1139/y88-116.
Using a whole-cell voltage-clamp technique, we identified two time- and voltage-dependent K+ currents: an early outward rectifier and a delayed outward rectifier in single vascular smooth muscle cells of rabbit aorta in culture. About 90% of the single cells tested showed a predominant delayed outward K+ current type. Both K+ currents were decreased by tetraethylammonium. In contrast, bethanidine sulphate (10(-4)M), a pharmacological analog of the cardiac antifibrillatory drug, bretylium tosylate, decreased the early outward K+ current, increased the delayed rectifier K+ current type, and hyperpolarized the resting membrane potential. Bethanidine was found to relax vascular smooth muscle. The vasodilatory effect of bethanidine is associated with the activation of a K+ current that is probably involved in keeping the membrane potential at the resting state, thereby depressing the excitability of the aortic vascular smooth muscle.
采用全细胞膜片钳技术,我们在培养的兔主动脉单个血管平滑肌细胞中鉴定出两种时间和电压依赖性钾电流:一种早期外向整流钾电流和一种延迟外向整流钾电流。约90%的受试单细胞表现为主要的延迟外向钾电流类型。两种钾电流均被四乙铵降低。相比之下,心脏抗纤颤药物溴苄铵的药理学类似物硫酸倍他尼定(10⁻⁴M)可降低早期外向钾电流,增加延迟整流钾电流类型,并使静息膜电位超极化。发现倍他尼定可舒张血管平滑肌。倍他尼定的血管舒张作用与一种钾电流的激活有关,该钾电流可能参与维持静息状态下的膜电位,从而降低主动脉血管平滑肌的兴奋性。